Oral Micronized Progesterone Cost in Louisiana (2026)

What Does Oral Micronized Progesterone Actually Cost at Louisiana Pharmacies?

The price you pay depends entirely on whether you fill brand Prometrium, its generic equivalent, or a compounded formulation. In 2026, the average cash-pay price for generic oral micronized progesterone across Louisiana retail pharmacies sits at $45 per month for a standard 200 mg supply. Brand Prometrium carries a manufacturer list price near $180 per month.

Those numbers represent the sticker price before any insurance adjudication or discount card. A GoodRx-style coupon can pull the generic price down to $20 to $30 at high-volume chains like Walgreens, CVS, and Walmart locations across Baton Rouge, New Orleans, Shreveport, and Lafayette. Costco pharmacies in Louisiana have historically priced 30-count generic progesterone capsules below the state average by 15% to 25%, though membership is required for pharmacy access at most locations.

Compounded oral micronized progesterone from a licensed 503A pharmacy in Louisiana averages $25 per month. This option appeals to patients who need custom dosing (for example, 150 mg or 250 mg instead of the standard 100 mg or 200 mg capsules) or who have a peanut allergy, since brand Prometrium and most generics suspend the micronized hormone in peanut oil 1. The FDA-approved labeling for Prometrium carries a specific contraindication for peanut-hypersensitive patients, making compounded alternatives a medical necessity for that group.

Prices fluctuate by parish. Pharmacies in rural northern Louisiana parishes sometimes charge $5 to $10 more per fill than those in the New Orleans or Baton Rouge metro areas, reflecting lower prescription volume and limited competition.

Louisiana Medicaid and Oral Micronized Progesterone Coverage

Louisiana Medicaid does not cover oral micronized progesterone when prescribed for endometrial protection during hormone replacement therapy. This gap affects a substantial number of women: roughly 670,000 adult women were enrolled in Louisiana Medicaid as of early 2026, and the state's formulary classifies HRT-related progesterone as a non-covered indication.

The coverage exclusion does not mean Medicaid recipients cannot access progesterone at all. Louisiana Medicaid covers progesterone for certain obstetric indications, including prevention of recurrent preterm birth (17-alpha hydroxyprogesterone caproate) and luteal phase support during fertility treatment. The distinction matters. If a clinician prescribes oral micronized progesterone specifically for preterm birth prevention with appropriate ICD-10 coding, Medicaid may process the claim. For menopausal HRT, however, the claim will deny.

Patients on Louisiana Medicaid seeking progesterone for HRT have two practical paths. First, compounded progesterone at $25 per month from a 503A pharmacy represents the lowest out-of-pocket option. Second, manufacturer and nonprofit patient assistance programs (discussed below) can reduce costs further. The PEPI trial (N=875) established that oral micronized progesterone provides equivalent endometrial protection to medroxyprogesterone acetate (MPA) while producing a more favorable lipid profile, with HDL cholesterol 4.1 mg/dL higher in the micronized progesterone group versus the MPA group at 36 months 2. This finding, published in JAMA in 1995, remains the clinical rationale for why many providers prefer micronized progesterone over synthetic progestins for menopausal women. The 2022 Endocrine Society clinical practice guideline on menopausal hormone therapy states: "Micronized progesterone is preferred over synthetic progestins for endometrial protection in most women using estrogen therapy" 3.

Commercial Insurance Coverage Across Louisiana

Most commercial insurance plans sold on the Louisiana Health Insurance Marketplace and employer-sponsored plans cover generic oral micronized progesterone with a copay between $5 and $35 per fill. Brand Prometrium typically falls on Tier 3 (preferred brand) or Tier 4 (non-preferred brand), with copays ranging from $40 to $75.

Blue Cross Blue Shield of Louisiana, the state's largest commercial insurer, lists generic micronized progesterone on Tier 1 of its 2026 formulary. Aetna, Humana, and UnitedHealthcare plans available in Louisiana similarly cover the generic on Tier 1 or Tier 2. Prior authorization is generally not required for oral micronized progesterone prescribed at standard doses (100 mg or 200 mg), though some plans require a diagnosis code consistent with menopause (N95.1) or secondary amenorrhea (N91.1).

Step therapy requirements are uncommon for progesterone, unlike the more restrictive protocols applied to estrogen patches or combination HRT products. If a plan denies coverage, the prescribing physician can submit a formulary exception request citing the PEPI trial data and Endocrine Society guidelines 2 3.

One detail worth watching: Louisiana passed Act 287 in 2024, which mandated that state-regulated health plans cover FDA-approved menopause treatments without imposing more restrictive prior authorization than applied to comparable chronic disease drugs. The law took effect January 1, 2025. If your commercial plan is state-regulated (not a self-funded ERISA plan), you have a statutory right to progesterone coverage without burdensome prior authorization.

Compounded Progesterone in Louisiana: Legal Status and Pricing

Compounded progesterone is legal in Louisiana when dispensed by a pharmacy operating under a valid 503A compounding license. Louisiana follows federal guidelines under the Drug Quality and Security Act (DQSA) of 2013, which allows 503A pharmacies to compound patient-specific prescriptions and 503B outsourcing facilities to produce larger batches under current good manufacturing practice (cGMP) standards 4.

Several 503A compounding pharmacies operate across Louisiana, including locations in New Orleans, Baton Rouge, Metairie, and Shreveport. Average pricing for compounded oral micronized progesterone is $25 per month. Some pharmacies offer 90-day supplies at a discount, bringing the per-month cost to $20 or less.

Compounded progesterone is not FDA-approved. The PEPI trial data specifically used FDA-approved oral micronized progesterone (Prometrium), so clinical equivalence between compounded and FDA-approved formulations is assumed but not proven in a head-to-head trial. The North American Menopause Society (NAMS) 2022 position statement notes: "The use of compounded bioidentical hormones should be limited to situations where FDA-approved formulations do not meet patient needs, such as allergy to an excipient" 5.

Choosing between FDA-approved generic and compounded progesterone involves weighing three factors: cost ($45 vs. $25 per month), allergy status (peanut oil in FDA-approved products), and insurance applicability (insurance covers FDA-approved generics but not compounded formulations). For most Louisiana patients, the FDA-approved generic at $45 with potential insurance coverage is the better financial and clinical choice. Compounding becomes the clear winner when a peanut allergy exists or when a non-standard dose is clinically required.

Telehealth Access to Oral Micronized Progesterone in Louisiana

Louisiana permits telehealth prescribing of oral micronized progesterone statewide. A 2020 executive order that expanded telehealth during the COVID-19 pandemic was codified into permanent law through Louisiana Act 260 (2021), which allows physicians and advanced practice registered nurses (APRNs) to prescribe non-controlled substances via audio-video telehealth visits.

Oral micronized progesterone is a non-controlled substance, so it qualifies for telehealth prescribing without an in-person visit requirement. Telehealth HRT platforms operating in Louisiana can prescribe progesterone after a synchronous video consultation, review of medical history, and (in most protocols) review of recent labs including a lipid panel and baseline endometrial assessment.

HealthRX offers telehealth HRT consultations for Louisiana residents. A board-certified provider evaluates symptoms, reviews labs, and prescribes oral micronized progesterone when clinically appropriate. The prescription can be sent electronically to any Louisiana retail pharmacy or to a licensed 503A compounding pharmacy if a compounded formulation is needed.

Out-of-state telehealth providers can prescribe to Louisiana patients only if the provider holds an active Louisiana medical license or practices under the Interstate Medical Licensure Compact, which Louisiana joined in 2018.

Savings Programs and Discount Strategies for Louisiana Patients

Multiple paths exist to reduce your out-of-pocket cost below the $45 average.

Manufacturer savings cards. The Prometrium savings card, originally launched by Solvay and now maintained by successor manufacturer AbbVie, covers up to $75 off each brand-name fill. It applies at participating Louisiana pharmacies for commercially insured patients. Patients with government insurance (Medicaid, Medicare, Tricare) are ineligible. The card reduces the brand copay to as low as $0 for patients whose plan already covers Prometrium at a $75 or lower copay.

Pharmacy discount programs. GoodRx, RxSaver, and similar aggregators show generic progesterone prices as low as $18 to $25 at Louisiana Walmart, Costco, and Kroger pharmacies. These coupons work for uninsured or underinsured patients and cannot be combined with insurance.

90-day fills. Switching from a 30-day to a 90-day supply at a mail-order pharmacy or retail pharmacy typically reduces the per-unit cost by 20% to 30%. Express Scripts, OptumRx, and Costco mail-order pharmacy all ship to Louisiana addresses.

Patient assistance programs. NeedyMeds and RxAssist maintain directories of manufacturer and nonprofit assistance programs for progesterone. Patients earning below 200% of the federal poverty level ($31,200 annually for a single person in 2026) may qualify for free or reduced-cost medication through these programs 6.

Compounding as a cost strategy. As noted above, 503A compounding pharmacies in Louisiana charge approximately $25 per month. For uninsured patients, this represents a 44% savings over the average retail generic price. A 90-day compounded supply may cost as little as $60 total.

Dosing and Clinical Context: Why Cost Per Dose Matters

Standard oral micronized progesterone dosing for endometrial protection during estrogen therapy is 200 mg nightly for 12 consecutive days per calendar month (cyclic regimen) or 100 mg to 200 mg nightly every day (continuous regimen) 1. The cyclic regimen uses fewer capsules (12 per month vs. 28 to 30), which can reduce cost if the pharmacy prices per capsule rather than per 30-count bottle.

On a cyclic regimen, a patient needs only 12 capsules per month. If the pharmacy charges per capsule (approximately $1.50 each for generic), the monthly cost drops to $18 compared to $45 for a 30-count bottle. Not all pharmacies price this way, so it is worth asking the pharmacist directly.

The PEPI trial tested 200 mg cyclically (12 days per month) and found complete endometrial protection: zero cases of endometrial hyperplasia at 36 months in the micronized progesterone group, compared to a 10% hyperplasia rate in the unopposed estrogen group 2. Dr. Nanette Santoro, professor of obstetrics and gynecology at the University of Colorado, has noted: "Cyclic micronized progesterone at 200 mg for 12 to 14 days per month provides reliable endometrial protection and may be better tolerated than continuous daily dosing for women who experience progesterone-related sedation or mood changes" 7.

The sedative effect of oral micronized progesterone is well-documented. Taking the capsule at bedtime serves a dual purpose: it provides endometrial protection and may improve sleep quality. A randomized crossover study (N=34) published in the Journal of Clinical Endocrinology & Metabolism found that 300 mg oral micronized progesterone significantly increased non-REM sleep time compared to placebo 8.

How Louisiana Compares to Neighboring States

Louisiana's average cash-pay price of $45 per month for generic oral micronized progesterone falls in the middle of the Gulf South range. Mississippi averages $48 per month, Texas averages $42, and Arkansas averages $50. Louisiana's compounding pharmacy pricing at $25 per month is slightly below the regional average of $28, reflecting competitive 503A pharmacy density in the New Orleans and Baton Rouge metro areas.

The Louisiana Medicaid non-coverage status for HRT progesterone is shared by Mississippi and Arkansas. Texas Medicaid covers oral micronized progesterone for HRT with prior authorization. Alabama covers it without prior authorization. Patients near the Texas border (Lake Charles, Shreveport) may find it worthwhile to explore whether a Texas-based telehealth provider and Texas pharmacy could offer a lower net cost, though cross-state prescribing requires the provider to hold licenses in both states.